Coding & Reimbursement

  •  - In 2018, the FDA granted breakthrough designation to the MI assay in DISCERN™ and FDA review is pending.
  •  - PLA codes for DISCERN™ test have been paid for by Medicare.
  •  - DISCERN™ test has been awarded two unique CPT (PLA) codes 206U (MI & PKC) diagnostic tests and 207U (AD index) confirmatory test.
2022 Medicare Fee For Service payments
206U$2,215.40
207U$511.20